262 related articles for article (PubMed ID: 16601450)
1. Cardiac connexins as candidate genes for idiopathic atrial fibrillation.
Gollob MH
Curr Opin Cardiol; 2006 May; 21(3):155-8. PubMed ID: 16601450
[TBL] [Abstract][Full Text] [Related]
2. The role of connexin40 in atrial fibrillation.
Chaldoupi SM; Loh P; Hauer RN; de Bakker JM; van Rijen HV
Cardiovasc Res; 2009 Oct; 84(1):15-23. PubMed ID: 19535379
[TBL] [Abstract][Full Text] [Related]
3. Paradigm of genetic mosaicism and lone atrial fibrillation: physiological characterization of a connexin 43-deletion mutant identified from atrial tissue.
Thibodeau IL; Xu J; Li Q; Liu G; Lam K; Veinot JP; Birnie DH; Jones DL; Krahn AD; Lemery R; Nicholson BJ; Gollob MH
Circulation; 2010 Jul; 122(3):236-44. PubMed ID: 20606116
[TBL] [Abstract][Full Text] [Related]
4. Cardiac connexins, mutations and arrhythmias.
Delmar M; Makita N
Curr Opin Cardiol; 2012 May; 27(3):236-41. PubMed ID: 22382502
[TBL] [Abstract][Full Text] [Related]
5. Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure.
Burstein B; Comtois P; Michael G; Nishida K; Villeneuve L; Yeh YH; Nattel S
Circ Res; 2009 Dec; 105(12):1213-22. PubMed ID: 19875729
[TBL] [Abstract][Full Text] [Related]
6. Atrial tachycardia/fibrillation in the connexin 43 G60S mutant (Oculodentodigital dysplasia) mouse.
Tuomi JM; Tyml K; Jones DL
Am J Physiol Heart Circ Physiol; 2011 Apr; 300(4):H1402-11. PubMed ID: 21239638
[TBL] [Abstract][Full Text] [Related]
7. Relationship between connexins and atrial activation during human atrial fibrillation.
Kanagaratnam P; Cherian A; Stanbridge RD; Glenville B; Severs NJ; Peters NS
J Cardiovasc Electrophysiol; 2004 Feb; 15(2):206-16. PubMed ID: 15028052
[TBL] [Abstract][Full Text] [Related]
8. Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs.
Sarrazin JF; Comeau G; Daleau P; Kingma J; Plante I; Fournier D; Molin F
J Am Coll Cardiol; 2007 Oct; 50(15):1505-12. PubMed ID: 17919572
[TBL] [Abstract][Full Text] [Related]
9. The Connexin40A96S mutation from a patient with atrial fibrillation causes decreased atrial conduction velocities and sustained episodes of induced atrial fibrillation in mice.
Lübkemeier I; Andrié R; Lickfett L; Bosen F; Stöckigt F; Dobrowolski R; Draffehn AM; Fregeac J; Schultze JL; Bukauskas FF; Schrickel JW; Willecke K
J Mol Cell Cardiol; 2013 Dec; 65():19-32. PubMed ID: 24060583
[TBL] [Abstract][Full Text] [Related]
10. In calcineurin-induced cardiac hypertrophy expression of Nav1.5, Cx40 and Cx43 is reduced by different mechanisms.
Bierhuizen MF; Boulaksil M; van Stuijvenberg L; van der Nagel R; Jansen AT; Mutsaers NA; Yildirim C; van Veen TA; de Windt LJ; Vos MA; van Rijen HV
J Mol Cell Cardiol; 2008 Sep; 45(3):373-84. PubMed ID: 18662696
[TBL] [Abstract][Full Text] [Related]
11. Gap junction alterations in human cardiac disease.
Severs NJ; Coppen SR; Dupont E; Yeh HI; Ko YS; Matsushita T
Cardiovasc Res; 2004 May; 62(2):368-77. PubMed ID: 15094356
[TBL] [Abstract][Full Text] [Related]
12. Chronic hemodynamic overload of the atria is an important factor for gap junction remodeling in human and rat hearts.
Rucker-Martin C; Milliez P; Tan S; Decrouy X; Recouvreur M; Vranckx R; Delcayre C; Renaud JF; Dunia I; Segretain D; Hatem SN
Cardiovasc Res; 2006 Oct; 72(1):69-79. PubMed ID: 16839528
[TBL] [Abstract][Full Text] [Related]
13. The cardiac gap junction: a potential therapeutic target in the treatment of heart disease.
Liu F; Gutstein DE
Mt Sinai J Med; 2002 Nov; 69(6):421-4. PubMed ID: 12429963
[TBL] [Abstract][Full Text] [Related]
14. Study on the spatial distribution pattern of Cx40 gap junctions in the atria of patients with coronary heart disease.
Zhou SH; He XZ; Liu QM; Du WH; Li XP; Zhou T; Tang JQ; Li RS
Cardiol J; 2008; 15(1):50-6. PubMed ID: 18651385
[TBL] [Abstract][Full Text] [Related]
15. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs.
Shiroshita-Takeshita A; Sakabe M; Haugan K; Hennan JK; Nattel S
Circulation; 2007 Jan; 115(3):310-8. PubMed ID: 17224477
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of atrial remodeling and clinical relevance.
Nattel S; Shiroshita-Takeshita A; Cardin S; Pelletier P
Curr Opin Cardiol; 2005 Jan; 20(1):21-5. PubMed ID: 15596955
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological modulation of gap junction function with the novel compound rotigaptide: a promising new principle for prevention of arrhythmias.
Kjølbye AL; Haugan K; Hennan JK; Petersen JS
Basic Clin Pharmacol Toxicol; 2007 Oct; 101(4):215-30. PubMed ID: 17845503
[TBL] [Abstract][Full Text] [Related]
18. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation.
Gollob MH; Jones DL; Krahn AD; Danis L; Gong XQ; Shao Q; Liu X; Veinot JP; Tang AS; Stewart AF; Tesson F; Klein GJ; Yee R; Skanes AC; Guiraudon GM; Ebihara L; Bai D
N Engl J Med; 2006 Jun; 354(25):2677-88. PubMed ID: 16790700
[TBL] [Abstract][Full Text] [Related]
19. Atrial gap junctions, NF-kappaB and fibrosis in patients undergoing coronary artery bypass surgery: the relationship with postoperative atrial fibrillation.
Li JY; Lai YJ; Yeh HI; Chen CL; Sun S; Wu SJ; Lin FY
Cardiology; 2009; 112(2):81-8. PubMed ID: 18580064
[TBL] [Abstract][Full Text] [Related]
20. High incidence of cardiac malformations in connexin40-deficient mice.
Gu H; Smith FC; Taffet SM; Delmar M
Circ Res; 2003 Aug; 93(3):201-6. PubMed ID: 12842919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
